Flolan

— THERAPEUTIC CATEGORIES —
  • Pulmonary hypertension

Flolan Generic Name & Formulations

General Description

Epoprostenol (as sodium) 0.5mg, 1.5mg; per vial; pwd for IV infusion after reconstitution.

Pharmacological Class

Prostacyclin analogue.

How Supplied

Vial—1 (w. diluent)

Manufacturer

Generic Availability

YES

Flolan Indications

Indications

Pulmonary arterial hypertension (PAH) (WHO Group I) in patients with NYHA Class III or IV symptoms, to improve exercise ability.

Flolan Dosage and Administration

Adult

Give by continuous chronic IV infusion through a central venous catheter. Initially 2ng/kg/min; increase in increments of 1–2ng/kg/min at ≥15min intervals based on response. Decrease dose gradually in 2ng/kg/min decrements at ≥15min intervals until dose-limiting effects resolve.

Children

Not established.

Flolan Contraindications

Contraindications

Heart failure due to reduced left ventricular ejection fraction.

Flolan Boxed Warnings

Not Applicable

Flolan Warnings/Precautions

Warnings/Precautions

Avoid abrupt withdrawal or large dose reductions (may cause rebound pulmonary hypertension). Discontinue if pulmonary edema occurs; do not restart. Increased risk for hemorrhagic complications. Monitor BP and symptoms of vasodilation during initiation and after dose changes. Pregnancy. Nursing mothers.

Flolan Pharmacokinetics

See Literature

Flolan Interactions

Interactions

Hypotensive effects may be potentiated by diuretics, antihypertensive agents, other vasodilators. Increased risk of bleeding with anticoagulants, antiplatelets.

Flolan Adverse Reactions

Adverse Reactions

Dizziness, jaw pain, headache, musculoskeletal pain, nausea, vomiting, flushing.

Flolan Clinical Trials

See Literature

Flolan Note

Not Applicable

Flolan Patient Counseling

See Literature